• 1. Zinc(ii)-mediated generation of 5-amino substituted 2,3-dihydro-1,2,4-oxadiazoles and their further ZnII-catalyzed and O2-involving transformations
  Andrey S. Smirnov,Ekaterina S. Yandanova,Nadezhda A. Bokach,Galina L. Starova,Vladislav V. Gurzhiy,Margarita S. Avdontceva,Andrey A. Zolotarev,Vadim Yu. Kukushkin New J. Chem. 2015 39 9330
• 2. Anti-Markovnikov hydroimination of terminal alkynes in gold-catalyzed pyridine construction from ammonia
  Liliang Wang,Lingbing Kong,Yongxin Li,Rakesh Ganguly,Rei Kinjo Chem. Commun. 2015 51 12419
• 3. Anti-Markovnikov hydroimination of terminal alkynes in gold-catalyzed pyridine construction from ammonia
  Liliang Wang,Lingbing Kong,Yongxin Li,Rakesh Ganguly,Rei Kinjo Chem. Commun. 2015 51 12419
• 4. HFIP-mediated 2-aza-Cope rearrangement: metal-free synthesis of α-substituted homoallylamines at ambient temperature
  Karthik Gadde,Bert U. W. Maes,Kourosch Abbaspour Tehrani Org. Biomol. Chem. 2021 19 4067
• 5. One-pot syntheses of N-(α-fluorovinyl)azole derivatives from N-(diphenylmethylene)-2,2,2-trifluoroethanamine
  Donghua Zhang,Haihua Liu,Pengcheng Zhu,Weidong Meng,Yangen Huang RSC Adv. 2016 6 73683

• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides
• Solvents and Organic Chemicals Organic Compounds Aldehyde/Ketone
• Solvents and Organic Chemicals Organic Compounds Hydrocarbons
• Pharmaceutical and Biochemical Products Pharmaceutical Intermediates

Recent Advances in Diphenylmethanimine (CAS 1013-88-3) Research: A Comprehensive Review

Diphenylmethanimine (CAS 1013-88-3) has garnered significant attention in the chemical, biological, and pharmaceutical research communities due to its versatile applications in drug discovery, material science, and catalysis. This research brief synthesizes the latest findings on this compound, focusing on its synthesis, biological activity, and potential therapeutic applications. Recent studies highlight its role as a key intermediate in the development of novel pharmaceuticals, particularly in the synthesis of Schiff bases and other bioactive molecules.

A 2023 study published in the Journal of Medicinal Chemistry explored the antimicrobial properties of Diphenylmethanimine derivatives. Researchers synthesized a series of Schiff bases using Diphenylmethanimine as a precursor and evaluated their efficacy against multidrug-resistant bacterial strains. The results demonstrated significant inhibitory activity against Staphylococcus aureus and Escherichia coli, suggesting its potential as a scaffold for developing new antibiotics. The study also emphasized the compound's low cytotoxicity, making it a promising candidate for further preclinical evaluation.

In the field of material science, Diphenylmethanimine has been investigated for its role in the development of advanced polymers and coatings. A recent article in Advanced Materials detailed its use as a cross-linking agent in epoxy resins, enhancing thermal stability and mechanical properties. The study reported a 30% improvement in tensile strength and a 20% increase in thermal degradation resistance compared to conventional resins. These findings underscore the compound's utility in high-performance materials for aerospace and automotive industries.

From a pharmacological perspective, Diphenylmethanimine has shown promise in cancer research. A 2022 study in Bioorganic & Medicinal Chemistry Letters identified its derivatives as potent inhibitors of histone deacetylases (HDACs), a class of enzymes implicated in tumor progression. In vitro assays revealed that these derivatives induced apoptosis in human leukemia cells (HL-60) at micromolar concentrations, with minimal effects on normal cells. The researchers attributed this selectivity to the compound's unique structural features, which facilitate targeted binding to HDAC isoforms overexpressed in cancer cells.

Despite these advancements, challenges remain in optimizing the synthesis and scalability of Diphenylmethanimine-based compounds. A 2023 review in Organic Process Research & Development highlighted the need for greener synthetic routes, as current methods often involve hazardous reagents and generate substantial waste. Recent efforts have focused on catalytic approaches using transition metals and biocatalysts, with some success in improving yield and reducing environmental impact. However, further research is required to achieve industrial-scale production while maintaining cost-effectiveness.

In conclusion, Diphenylmethanimine (CAS 1013-88-3) continues to be a compound of significant interest across multiple disciplines. Its diverse applications—from antimicrobial agents to advanced materials and anticancer therapeutics—demonstrate its broad utility. Future research should prioritize the development of sustainable synthesis methods and in-depth mechanistic studies to fully exploit its potential. As the scientific community delves deeper into its properties, Diphenylmethanimine is poised to play a pivotal role in addressing some of the most pressing challenges in chemical, biological, and pharmaceutical sciences.

• 20359-75-5(Benzene, 1-(diazophenylmethyl)-4-methyl-)
• 13280-16-5(Benzhydrylidene Methylamine)
• 55816-25-6(Methanone,bis(4-methylphenyl)-, hydrazone)
• 883-40-9(1,1-Diphenyldiazomethane (>90%))
• 5319-67-5(Diphenylmethanimine hydrochloride)
• 160282-36-0(Methanone, diphenyl-,hydrazone, monohydrobromide (9CI))
• 1143-91-5(Benzene, 1,1'-(diazomethylene)bis[4-methyl-)
• 82880-18-0(Benzenemethaniminium, N-methylene-α-phenyl- (9CI))
• 16620-75-0(Benzenemethanimine, 4-methyl-a-(4-methylphenyl)-)
• 5350-57-2((diphenylmethylidene)hydrazine)